Regenerative Medical Technology Group Inc.
RMTG
$0.03
$0.0027.14%
OTC PK
| 03/31/2025 | 12/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -9.70% | 53.18% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -9.70% | 53.18% | |||
| Cost of Revenue | -20.77% | 121.82% | |||
| Gross Profit | -3.70% | 31.20% | |||
| SG&A Expenses | 21.14% | -1.61% | |||
| Depreciation & Amortization | 286.33% | -131.31% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 9.00% | 17.09% | |||
| Operating Income | -64.75% | 1,558.01% | |||
| Income Before Tax | -19.08% | 28.06% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -19.08% | 28.06% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -19.08% | 28.06% | |||
| EBIT | -64.75% | 1,558.01% | |||
| EBITDA | -57.36% | 291.51% | |||
| EPS Basic | -19.06% | 28.11% | |||
| Normalized Basic EPS | -19.18% | 28.05% | |||
| EPS Diluted | -19.06% | 28.11% | |||
| Normalized Diluted EPS | -19.18% | 28.05% | |||
| Average Basic Shares Outstanding | 0.00% | 0.00% | |||
| Average Diluted Shares Outstanding | 0.00% | 0.00% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||